Cognivue is a Proud Corporate Sponsor of the Alzheimer's Association Walk to End Alzheimers

Visit our booth at any of the walk locations.

See Locations
Alzheimers Walk Logo

Cognivue® is a risk assessment test that was designed to identify changes in cognitive function that could be indicative of early dementia or Alzheimer's Disease.

The World's First FDA-Cleared Computerized Test of Cognitive Function.

Take the Product Tour
Doctor and patient

The performance of Cognivue as a risk assessment test allows the clinician to:

Identify

patients at risk earlier

Stratify

patients at risk of cognitive impairment

Mitigate

risk by implementing their protocols and strategies for care

Doctor and Patient

Highlights & Benefits

Cognivue is a risk assessment test that objectively, quantitatively and reliably identifies changes in cognitive function that could be indicative of early dementia or Alzheimer's Disease.

Early Detection

Early risk assessment score allows for early identification, risk stratification and intervention to improve patient care.

Simple Overall Score

Scientific based algorithm that automatically calculates an average risk score that's easy to interpret and understand.

10 Minute Test

Rapid and objective risk score of cognition. Results are comparable across all devices and locations.

Patient Administered

Easy test for staff to set up and patients to take and easily accommodates clinical workflow.

Tests 4 Key Cognitive Domains

A series of sub-tests used to measure motor control, visual processing, perception and memory.

Reimbursable

Accepted by Medicare and most insurance companies.

Simple test results. Easy to understand. Easy to communicate.

Upon completion of the 10 minute test, Cognivue immediately creates a report with a clinical risk score of cognitive health. Using the patient's risk score, you will be able to determine the proper course of action. You can mitigate risk by implementing protocols and strategies to improve patient care.

Learn About our Report
Cognivue Device

Revolutionary Technology

Cognivue was intuitively designed to eliminate testing variables. It protects from distractions and light interference and provides the same testing environment between multiple testing sites. The adaptive psychophysics of Cognivue focuses on cortical information processing by testing four key cognitive domains.

Take a Product Tour

Testimonials

It improved my ability to work with dementia patients and their CGs…I especially like the graphics.

Dr. R. Mittereder, Unity Geriatrics

News

Cognivue Featured in Local TV News

Local news reporter, Ashley Doerzbacher, visited our office in Victor, New York to learn about Cognivue and how the test identifies changes in cognitive function and can be used as an early indicator of…

Sign-up to schedule a Cognivue demo!

Click Here